Summit Global Investments’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-8,100
Closed -$481K – 617
2023
Q1
$481K Sell
8,100
-4,700
-37% -$261K 0.04% 355
2022
Q4
$625K Sell
12,800
-203
-2% -$9.38K 0.05% 276
2022
Q3
$671K Buy
13,003
+6,803
+110% +$404K 0.06% 261
2022
Q2
$326K Buy
+6,200
New +$431K 0.03% 384

Other funds holding THC

Summit Global Investments's THC Position: Q2 2023 in Review

Summit Global Investments sold out of Tenet Healthcare (THC) in Q2 2023, closing a stake of 8,100 shares — an estimated $481K sold.

Summit Global Investments first reported a position in THC in Q2 2022 and held it in 4 quarters. The position peaked at $671K in Q3 2022. 416 funds tracked by Wall St. Rank hold THC as of Q2 2023.

  • Summit Global Investments reported no remaining Tenet Healthcare position as of Q2 2023 after selling out during the quarter.
  • Summit Global Investments sold 8,100 Tenet Healthcare shares in Q2 2023, an estimated $481K.
  • Summit Global Investments first reported a position in Tenet Healthcare in Q2 2022 and held it in 4 quarters.
  • Summit Global Investments's Tenet Healthcare position peaked at $671K in Q3 2022.
  • 416 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2023.

Based on Summit Global Investments's 13F filing for Q2 2023, filed 19 Jul 2023.